163 related articles for article (PubMed ID: 13158)
1. The effects of repeated D-lysergic acid diethylamide injections on catecholamine levels and tyrosine hydroxylase activity in rat brain regions.
Peters DA; Tang S
J Neurochem; 1977 Jan; 28(1):59-62. PubMed ID: 13158
[No Abstract] [Full Text] [Related]
2. Effects of LSD and BOL on the catecholamine synthesis and turnover in various brain regions.
Persson SA
Psychopharmacology (Berl); 1978 Oct; 59(2):113-6. PubMed ID: 31650
[TBL] [Abstract][Full Text] [Related]
3. Catecholamine levels and tyrosine hydroxylase activities in rat brain regions after chronic treatment with, and withdrawal of, methamphetamine.
Bardsley ME; Bachelard HS
Biochem Pharmacol; 1981 Jun; 30(12):1543-9. PubMed ID: 6115646
[No Abstract] [Full Text] [Related]
4. Regulation of catecholamine synthesis in rat brain synaptosomes.
Patrick RL; Barchas JD
J Neurochem; 1974 Jul; 23(1):7-15. PubMed ID: 4153038
[No Abstract] [Full Text] [Related]
5. Comparison of the chronic and acute effects of D-lysergic acid diethylamide (LSD) treatment on rat brain serotonin and norepinephrine.
Peters DA
Biochem Pharmacol; 1974 Jan; 23(2):231-7. PubMed ID: 4149793
[No Abstract] [Full Text] [Related]
6. Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
Fuxe K; Nyström M; Tovi M; Smith R; Ogren SO
J Psychiatr Res; 1974; 11():151-61. PubMed ID: 4156786
[No Abstract] [Full Text] [Related]
7. Effects of some psychotropic drugs on tyrosine hydroxylase activity in different structures of the rat brain.
Besson MJ; Cheramy A; Gauchy C; Musacchio J
Eur J Pharmacol; 1973 May; 22(2):181-6. PubMed ID: 4146008
[No Abstract] [Full Text] [Related]
8. Release of endogenous catecholamines from isolated rat brain tissue by fenfluramine and N-ethylamphetamine--effects of pargyline.
Tessel RE; Burgess SK; Rutledge CO
Biochem Pharmacol; 1978; 27(12):1631-6. PubMed ID: 697904
[No Abstract] [Full Text] [Related]
9. Catecholamine concentrations and the activity of tyrosine hydroxylase after an increase in the concentration of tyrosine in rat tissues.
Dairman W
Br J Pharmacol; 1972 Feb; 44(2):307-10. PubMed ID: 4148919
[TBL] [Abstract][Full Text] [Related]
10. The accumulation of p-hydroxyamphetamine by brain homogenates and its role in the release of catecholamines.
Cho AK; Fischer JF; Schaeffer JC
Biochem Pharmacol; 1977 Aug; 26(15):1367-72. PubMed ID: 901551
[No Abstract] [Full Text] [Related]
11. Effect of perinatal undernutrition on the metabolism of catecholamines in the rat brain.
Shoemaker WJ; Wurtman RJ
J Nutr; 1973 Nov; 103(11):1537-47. PubMed ID: 4148058
[No Abstract] [Full Text] [Related]
12. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
Hungen KV; Roberts S; Hill DF
Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
[TBL] [Abstract][Full Text] [Related]
13. Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone.
Agarwal RA; Rastogi RB; Singhal RL
Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):743-52. PubMed ID: 12549
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge.
Masana MI; Heyes MP; Mefford IN
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(4):609-21. PubMed ID: 2236587
[TBL] [Abstract][Full Text] [Related]
15. A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism.
Stolk JM; Barchas JD; Goldstein M; Boggan W; Freedman DX
J Pharmacol Exp Ther; 1974 Apr; 189(1):42-50. PubMed ID: 4823298
[No Abstract] [Full Text] [Related]
16. Lysergic acid diethylamide: evidence for stimulation of cerebral dopamine receptors.
Prada MD; Saner A; Burkark WP; Bartholini G; Pletscher A
Brain Res; 1975 Aug; 94(1):67-73. PubMed ID: 1148867
[TBL] [Abstract][Full Text] [Related]
17. LSD: effect on monoamine metabolites in rat prefrontal cortex.
Bowers MB; Salomonsson LA
Biochem Pharmacol; 1982 Dec; 31(24):4093-6. PubMed ID: 6186259
[No Abstract] [Full Text] [Related]
18. Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.
Fuxe K; Fredholm BB; Agnati LF; Ogren SO; Everitt BJ; Jonsson G; Gustafsson JA
Pharmacology; 1978; 16 Suppl 1():99-134. PubMed ID: 643908
[No Abstract] [Full Text] [Related]
19. Role of tyrosine in the acute effects of ethanol on rat brain catecholamine synthesis.
Badawy AA; Williams DL; Evans M
Pharmacol Biochem Behav; 1983; 18 Suppl 1():389-96. PubMed ID: 6138774
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of dl-p-methoxyamphetamine and d-amphetamine on catecholamine release and reuptake in vitro.
Tseng LF; Hitzemann RJ; Loh HH
J Pharmacol Exp Ther; 1974 Jun; 189(3):708-16. PubMed ID: 4843169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
